Zogenix Inc. buy melinda
Start price
22.06.17
/
50%
€13.44
Target price
29.09.17
€30.00
Performance (%)
79.10%
End price
29.09.17
€24.07
Summary
This prediction ended on 29.09.17 with a price of €24.07. The BUY prediction by melinda for Zogenix Inc. saw massive gains of 79.10%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by melinda for this prediction
In the thread Zogenix Inc. diskutieren
* Zogenix Inc. - 22. Juni erteilte die US FDA seine experimentelle Droge, die Ausweisung von Orphan - ZX008 Medikament für die Behandlung von Lennox-Gastaut - Syndrom
(Vom Mitglied beendet)